Written question asked by Lord Taylor of Goss Moor (Liberal Democrat) on Monday, 25 June 2001, in the House of Commons. It was due for an answer on Monday, 2 July 2001. It was answered by Lord Moonie (Labour) on Monday, 2 July 2001 on behalf of the Ministry of Defence.
Ministry of Defence
- Question
- To ask the Secretary of State for Defence, if he will instruct the chemical defence establishment, Porton Down, to conduct research to determine the long-term effects of a single dose of the oripavine derivative TL 2636 on the health of humans.
- Answer
-
Matthew Taylor: To ask the Secretary of State for Defence if he will instruct the chemical defence establishment, Porton Down, to conduct research to determine the long-term effects of a single dose of the oripavine derivative TL 2636 on the health of humans. [989] Dr. Moonie: No. The current evidence suggests that following single, acute doses of the oripavine derivative TL 2636 there are no long-term effects on health. The conduct of a study is, therefore, not warranted.
Secondary information
- Type
- Written question
- Reference
- 989; 371 c3W
- Session
- 2001-02
- Subjects
- Chemical and biological warfare Chemical weapons Health hazards Research Defence Evaluation and Research Agency Human experiments Porton Down (Wiltshire) Oripavine
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2022-02-11 19:46:06 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_669453
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_669453
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_669453